Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5648)	9/23/1998 7:40:00 PM
From: mc	Read Replies (1) \| Respond to of 7041

I've read every message on this thread and don't recall it other than your continued repetition without reference to supporting documents. It is probably out there, but, I don't really care to look for it. Your statement that it came from the PDR is enough for me. However, if you are going to use biodoc's postings from the PDR as support I would suggest that it is insufficient. As we know from from some of the Zonagen research, the PDR information is often insufficient and possibly incorrect. I would like to see more recent and thorough support for this argument other than the outdated information in the PDR. Has anyone out there had the opportunity to see the labeling on Vasomax being sold in Mexico? That would be a good start. Gary